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ABSTRACT 
Objectives: To investigate the association of total urinary polyphenols (TUP) and total 
dietary polyphenols (TDP) with cognitive decline in an older population. 
Design: The Invecchiare in Chianti (InCHIANTI) study, a cohort study with a 3-year of 
follow-up. Setting: tuscany, italy. Participants: Non-demented adults aged 65 and older 
(N=652). Measurements: TUP and TDP concentrations were analysed at baseline using 
the Folin-Ciocalteu assay and a validated food frequency questionnaire, respectively. 
Cognition was assessed using the Mini-Mental State Examination (MMSE) and Trail 
Making Test (TMT) at baseline and after three years of follow-up. A substantial cognitive 
decline was defined as a reduction in the MMSE score of 3 or more points and as an 
increase of at least 29 seconds on the TMT A and 68 seconds on the TMT B (these 
thresholds represent the worst 10% of the distribution of decline) or as test discontinued 
due to multiple mistakes in TMT A and B at follow-up. Results: Higher TUP levels were 
associated with lower risk of substantial cognitive decline on the MMSE (odds ratio [OR] 
comparing extreme tertiles = 0.53; 95% confidence interval [CI] = 0.34–0.85; P-trend = 
0.008) and on the TMT-A (OR = 0.52; 95 % CI = 0.28–0.96; P-trend = 0.03), but not on 
TMT-B in a logistic regression model that adjusted for baseline cognitive score and 
potential confounding factors. TDP did not affect the developing substantial cognitive 
decline in both tests. Conclusion: High concentrations of polyphenols, a nutritional 
biomarker of polyphenol intake, were associated with a lower risk of substantial cognitive 
decline in the older population studied over a three-year period, suggesting a protective 
effect against cognitive impairment.  
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INTRODUCTION 
Cognitive decline in older persons encompasses a number of different conditions, from a 
physiological age-associated reduction of cognitive functions that occurs in almost every 
aging individual, the cognitive impairment that often accompanies a global deterioration of 
health and comorbidity, up to the accelerated trajectory of cognitive decline that eventually 
leads to mild cognitive impairment and dementia.
1,2
 
There is increasing literature suggesting that dietary factors,
3
 and in particular long-chain 
omega-3 fatty acids, low saturated-fat intake and high vegetable intake, are related to 
cognitive performance in older subjects.
4
 Over the last few years, there has been much 
scientific and public health interest in polyphenols
5
 due to their potential beneficial effects 
against chronic diseases, particularly cardiovascular diseases, type 2 diabetes and some 
cancers, and overall mortality.
6-11
 These secondary plant metabolites are natural bioactive 
compounds, which have been identified in foods and beverages.
12
 Several epidemiological 
studies have suggested that polyphenol-rich diets are positively associated with a better 
cognitive function.
13,14
 The neuroprotective activity of dietary polyphenols might be due to 
their antioxidant and anti-inflammatory properties.
15
 
The protective effects of polyphenols against human diseases depend on the quantity 
consumed and their bioavailability, which largely differs both between compounds and 
between subjects (inter-individual variation), and within subjects (intra-individual 
variation).
16
 In this context, a nutritional biomarker of total dietary polyphenols is essential 
to provide an accurate assessment of polyphenol exposure in order to evaluate their 
protective effects.
17
 Total urinary polyphenol (TUP) concentration determined by the Folin-
Ciocalteu assay, preferably analysed in 24-h urine samples,
18
 is considered an objective 
biomarker of total dietary polyphenol intake (TDP),
17,18
 and a proxy measure of dietary 
fruit and vegetable intake.
19
 To the best of our knowledge, there is only one recent cross-
sectional study showing that high TUP concentrations, expressed by urinary creatinine, 
were associated with better scores in immediate verbal memory in older subjects at high 
vascular risk.
20
 We aimed at expanding these findings in a longitudinal perspective by 
studying the effect of baseline TUP concentrations, expressed by 24-h volume, and TDP, 
and the risk of developing cognitive decline over a three-year period in older participants 
free of dementia at baseline who were enrolled in the InCHIANTI (Invecchiare in Chianti, 
Aging in the Chianti region) study. 
 
METHODS 
Study population 
The InCHIANTI (www.inchiantistudy.net) is an ongoing prospective community-based 
study designed to evaluate risk factors affecting the loss of mobility in the older population. 
It was conducted in Bagno in Ripoli and Greve in Chianti, two Italian towns adjacent to the 
city of Florence (Tuscany, Italy). Further details of the rationale and the study design have 
been described elsewhere.
21
 The study protocol was approved by the Italian National 
Research Council of Aging Ethical Committee, and all participants provided an informed 
participation consent.  
Data were collected at baseline and three years after enrolment. Baseline visits occurred 
between 1998 and 2000, and three-year assessments took place between 2001 and 2003. 
The study randomly sampled 1260 men and women aged 65 years and older, of whom 
1155 agreed to participate (participation rate = 91.6%). Of these, we excluded 82 
participants (7.1%) who were diagnosed with dementia syndrome at baseline by 
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geriatricians and psychologists with expertise in cognitive impairment. The final sample for 
the current analysis included 652 dementia-free adults aged 65 years or older who provided 
complete 24-h urine collection and had completed cognitive assessment after three years of 
follow-up. Follow-up data for Trails A and B were available for 510 and 423 participants, 
respectively (Figure 1). 
 
Total polyphenols exposure 
Twenty-four hour urine samples were collected at baseline. Urine samples were drawn, 
processed and stored at –80ºC until analysis. Total urinary polyphenols (TUP) were 
analysed by F-C assay, after solid-phase extraction as described previously.
18,19
 TUP 
concentrations were expressed as mg gallic acid equivalents (GAE)/d.  
Food intake (g/day) was assessed using the Italian version of the food frequency 
questionnaire developed and validated in the European Prospective Study into Cancer and 
Nutrition (EPIC) study.
22
 Briefly, a self-administered quantitative dietary questionnaire, 
including 236 food items and structured by courses within a meal characteristic of Italian 
dietary habits, was used. Portion sizes were estimated using natural units, household 
measures and grammage, or with the aid of a set of photographs. Energy (kcal/d) intake 
was calculated using an Italian food composition database created for the EPIC study.
23
 
TDPs were estimated using our food composition database on polyphenols.
11
 It was 
compiled from the three most updated U.S. Department of Agriculture databases 
(flavonoids, isoflavones, and proanthocyanidins)
24-26
 and the Phenol-Explorer database.
27
 
TDP intake was calculated as the sum of flavonoids (anthocyanidins, flavonols, flavanones, 
flavones, flavanols [including flavan-3-ol monomers, theaflavins and proanthocyanidins] 
and isoflavones), phenolic acids, lignans, stilbenes and other polyphenols, and was 
expressed as aglycone equivalents (mg/day),
27
 after the conversion of polyphenol glycoside 
and ester contents into aglycone contents on the basis of their respective molecular weights. 
 
Cognitive tests 
The mini-mental state examination (MMSE) is a validated method to assess global 
cognitive function, widely used in both clinical practice and research, and is an effective 
screening tool for cognitive impairment in older, community-dwelling, hospitalized and 
institutionalized adults.
28,29
 MMSE is an 11-question test that evaluates five areas of 
cognitive function: orientation, registration, attention and calculation, recall, and language. 
Scores for the MMSE range from 0 to 30, with higher scores indicating better cognitive 
function. The trail making tests (TMT) is a neuropsychological test commonly used in 
clinical evaluation for the assessment of cognitive abilities such as visual-conceptual and 
visual-motor tracking, sustained attention, and task alternation abilities.
30,31
 The TMT 
consists of two parts administered in sequence: TMT-A and TMT-B. Part A is focused 
particularly on attention, whereas Part B is focused on executive function. Worse 
performance is indicated by longer times, measured in seconds, to complete the Trails A 
and B.  
A substantial cognitive decline was defined as a decline in the MMSE score of 3 or more 
points from baseline to three years later,
28,29
 and as an increase of at least 29 seconds on the 
TMT-A and 68 seconds on the TMT-B (these thresholds represent the worst 10% of the 
distribution of subtracting baseline from three-year follow-up scores in seconds) or the test 
discontinued at follow-up, but not at baseline, due to multiple mistakes in TMT-A and 
TMT-B.
32
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Other baseline covariates 
Trained clinicians ascertained diseases based on information from self-reported physician 
diagnoses, drug treatments, medical history, clinical examinations and blood tests. Smoking 
status (current, former, and never a smoker), age, sex, education (years of schooling) and 
body mass index (kg/m
2
) were reported or measured. Physical activity was measured using 
a modified standard questionnaire
33
 and was defined as: 1) sedentary (completely inactive 
or performing light-intensity physical activity less than <2h/wk.); 2) light physical activity 
(light-intensity physical activity of 2–4h/wk.); and 3) moderate to high physical activity 
(light-intensity physical activity of at least >4h/wk. or moderate-intensity physical activity 
at least 1–2 h/wk.). Specific co-morbidities considered in this analysis were congestive 
heart failure, stroke, cancer and diabetes. Renal function was calculated using the 
Cockcroft–Gault formula: (140−Age) x Weight x [0.85 if female] / (72 x Serum Creatinine) 
and was classified into a dichotomous variable: normal renal function (≥60mL/min) and 
impaired renal function (<60mL/min).
34
 Depressive symptoms were assessed using the 
Center for Epidemiological Studies-Depression Scale (CES-D) and were defined as CES-D 
of 16 or higher and CES-D lower than 16.
35
 Total blood cholesterol was measured using an 
automated enzymatic method.
36
 
 
Statistical analysis 
Descriptive statistics were used to describe participants’ characteristics, means and standard 
deviations (SD) for normal continuous variables, medians and interquartile ranges (IQR) 
for variables with asymmetric distribution, and number of participants and percentages for 
categorical variables. Baseline characteristics were compared across TUP and TDP tertiles 
using age-adjusted generalized linear models. Spearman correlations were used to explore 
the relationships between TUP, TDP and the sum of fruit and vegetable intake. Linear 
regression models were used to evaluate associations between baseline cognitive 
performance (MMSE, TMT-A and TMT-B) and TDP and TUP tertiles. For TMT test 
performance, the inverse score was used; thus, a higher score corresponded to a better 
result. Logistic regression models were used to calculate odds ratios (ORs) and 95% 
confidence intervals (CIs) between TUP and TDP concentrations and substantial cognition 
decline. In unadjusted models, we controlled for baseline cognitive score only (Model A). 
In multivariable models, we adjusted for variables that have been identified as potential 
confounders: sex, age, education, body mass index, total energy intake, physical activity, 
baseline cognitive score, impaired renal function, smoking status, congestive heart failure, 
cancer, stroke, diabetes, depressive symptoms and total blood cholesterol (Model B). TUPs 
were analysed as tertiles of the whole cohort according to the following cut-off points: 
126.4 and 175.5 mg GAE/d urine. TDPs were also categorized as tertiles of the whole 
cohort according to the following cut-off points: 514.2 and 648.4 mg/d aglycones. Tests for 
linear trend were performed by considering the median of each tertile as an ordinal 
variable. TUPs and TDPs were also analysed as a log2-transformed continuous variables 
since they were not normally distributed. Interactions between TDP and TUP 
concentrations and sex, age, BMI, education and smoking status were tested by including 
product terms in fully adjusted logistic regression models. There was no evidence of 
colinearity. In sensitivity analyses, we assessed models for TDP excluding participants in 
the top or the bottom 1% of the distribution of the ratio of reported total energy intake to 
estimated energy requirement to minimize the potential effect of over- and under-reporters. 
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All statistical tests were two-tailed and were performed using the SPSS package program, 
version 20.0 (SPSS, Chicago, IL). The significance level was p<0.05. 
 
RESULTS 
The main characteristics of the study population according to tertiles of TUP and TDP, 
adjusted for age, are summarized in Table 1. The study included 361 women (55.4%) and 
291 men (44.6%) with a mean age of 73 years. From the lowest to the highest TUP tertiles, 
participants were younger and more likely to be men. The percentage of participants who 
experienced substantial cognitive decline on TMT-A over the three-year follow-up, and of 
those who at baseline had depressive symptoms and cancer progressively decreased with 
increasing TUP tertiles. While the inverse associations between TUP tertiles and substantial 
cognitive decline and change in cognitive score on MMSE were borderline significant. 
Moreover, from the lowest to the highest TUP tertiles, participants had a higher energy 
intake. There were no significant differences across the tertiles of TUP in BMI, education, 
smoking status, physical activity, fruit and vegetable consumption, total cholesterol, 
congestive heart failure and stroke. From the lowest to the highest tertiles of TDP, 
participants were younger, with a lower proportion of women, less often current and former 
smokers, had a higher education, physical activity, energy dietary intake, dietary fruit and 
vegetable consumption, and had lower total cholesterol. Participants with a substantial 
cognitive function decline after three-years of follow-up were older and more likely to be 
women, had a lower educational achievement and physical activity level, and a higher 
prevalence of stroke and congestive heart failure than those without cognitive decline. 
Participants excluded from this study (n=503) were significantly older (P<0.001), took 
more medications (P=0.04), had lower physical activity (P<0.001), and had more often 
renal impairment (P=0.006) than those included, whereas there were no significant 
differences in sex and smoking status (results not shown). TUP were significantly 
correlated with the intake of fruit and vegetables (rho=0.141; P<0.001) and TDP 
(rho=0.131; P<0.001). 
In linear regression models adjusted for potential confounding factors, TUP levels were 
positively associated with the MMSE (β = 0.076; SE = 0.243, P = 0.042) and the TMT-A 
(β = 0.086; SE = 5.174, P = 0.016), but not with the TMT-B (β = 0.014; SE = 6.835, P = 
0.73). No associations between TDP intake and any of the cognitive tests at baseline were 
observed. 
In logistic regression models adjusting for baseline cognitive scores and compared to 
participants in the lowest TUP tertile, those in the highest TUP tertile were significantly 
less likely to experience substantial cognitive decline both when assessed by the MMSE 
(OR = 0.53; 95% CI = 0.35–0.80; P-trend = 0.003) and the TMT-A (OR = 0.50; 95% CI = 
0.28–0.89; P-trend = 0.02) (Table 2, Model A). This association remained statistically 
significant after full adjustment for potential confounders both for the MMSE (highest vs. 
lowest tertile OR = 0.53; 95% CI = 0.34–0.85; P-trend = 0.008) and the TMT-A (OR = 
0.52; 95% CI = 0.28–0.96; P-trend = 0.03). No significant association between TUP 
concentrations and TMT-B was observed (Table 2, Model B). In fully adjusted models 
using MMSE, TMT-A and TMT-B tests, no statistically significant interactions were 
detected for sex, age, BMI, education and smoking status.  
In multivariable logistic models adjusted for all confounders, no statistically significant 
associations were found between TDP and substantial cognitive decline risk using the 
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MMSE (highest vs. lowest tertile OR = 1.08; 95% CI = 0.65–1.78; P-trend = 0.84), the 
TMT-A (OR = 0.63; 95% CI = 0.32–1.25; P-trend = 0.17) and the TMT-B (OR = 1.16; 
95% CI = 0.63–2.14; P-trend = 0.77) (Appendix Table S1, Model B). Again, we found no 
significant interactions between MMSE, TMT-A or TMT-B and sex, age, BMI, education, 
and smoking status.  
Sensitivity analyses were performed by excluding from the analysis participants in the top 
or the bottom 1% of the distribution of the ratio of total energy intake for TDP. The odds 
ratios for the sensitivity analyses were nearly identical to the results based on the whole 
cohort (data not shown). 
 
DISCUSSION 
In this population-based study of non-demented older people, high concentrations of TUP 
were associated with an approximate 47 and 48% reduction of the risk of substantial 
cognitive decline in global cognitive function (tested using the MMSE) and in attention 
(measured using the TMT-A) over a three-year period, respectively, but not with the TMT-
B, which is mainly focused on measuring executive function. No significant association 
was found between TDP and any cognitive test, as was also observed with all-cause 
mortality in a previous InCHIANTI study.
11
 This may be due to the difficulty in assessing 
TDP intake. While a part of polyphenol intake, TUP also accounts for the bioavailability of 
polyphenols
16
 and may therefore be a more precise measure of true exposure due to the 
large variability between and within polyphenol absorption and metabolism.
17
 
In a cross-sectional study, total polyphenols expressed by urinary creatinine normalization 
were linearly associated with better scores in immediate verbal memory in older adults at 
high cardiovascular risk.
20
 In the middle-aged SU.VI.MAX cohort, high total polyphenol 
intake, estimated using six repeated 24h dietary recalls, was associated with better language 
and verbal memory after a follow-up of 13 years.
14
 Similar to our results between TUP or 
TDP and TMT-B, no significant associations were observed between TDP and executive 
functioning in the SU.VI.MAX study
14
. Furthermore, in other prospective studies, the 
intake of flavonoids was associated with a better cognitive evolution in dementia-free older 
adults
13
 and a lower risk of Alzheimer’s disease, the most common form of dementia.37,38 In 
another prospective study, the consumption of fruit and vegetables, and thus antioxidant 
nutrients (vitamin E and C), was associated with better verbal memory.
39
 
In the present study, higher levels of TUP at baseline also had a better cognitive 
performance as in the PREDIMED study.
20
 However, no association was observed with 
TDP. As far as we know, no cross-sectional studies have focused on the relationship 
between TDP and cognitive function. In a small subsample of post-menopausal women 
from the PROSPECT study, which is one of the Dutch cohorts included in the EPIC study, 
higher intakes of lignans, but not isoflavones, were associated with higher MMSE scores at 
enrolment.
40
 Whereas, in the Lothian Birth Cohort 1936, flavonoid intake was not 
associated with any of the cognitive tests performed after adjusting for confounding factors 
at the age of 70 years old.
41
 
The potential mechanisms of the protective effects of polyphenols on cognitive functions 
may be linked to their antioxidant and anti-inflammatory properties. It is known that 
polyphenols reduce neuronal damage and death from oxidative reactions by inhibiting the 
generation of reactive oxygen species, lipid peroxidation, apoptosis, protein oxidation, 
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metal chelation and damage to cellular signaling.
15,42-46
 Potential actions of polyphenols 
may be mediated by the direct interactions within ERK and PI3-kinase/Akt signalling 
pathways, which have been associated with the maintenance of the number and quality of 
synaptic connections in key brain regions.
47
 Additional mechanisms are related to the 
inhibition of neuronal apoptosis activated by neurotoxic species or the disruption of 
amyloid β aggregation and effects on amyloid precursor protein processing through the 
inhibition of β-secretase and/or activation of α-secretase.47 
Our study has several strengths. First of all, to the best of our knowledge, this is the first 
prospective study to investigate the association between total polyphenols and substantial 
cognitive decline in an older population. Moreover, urinary polyphenols expressed by 24-h 
volume are an objective biomarker of total phenolic intake
18
 and a proxy biomarker of fruit 
and vegetable consumption.
19
 The main advantage of a nutritional biomarker over a dietary 
biomarker is that it is a more precise and more proximal measure than dietary assessment.
48
 
Currently, the adapted F-C assay in urine samples is considered a valid biomarker for total 
polyphenol intake and is a rapid, economic and easy method to apply to large-scale 
epidemiological studies. TUP expressed as 24-h volume is considered the gold standard to 
assess urinary excretion.
18
 Then cognitive functions were assessed using the MMSE – the 
most widely used instrument for measuring the course of cognitive change in an older adult 
over time
28,29– and TMT-A and TMT-B, which are also commonly used in the assessment 
of psychomotor speed, visuospatial scanning, and executive ability.
30,31
 Finally, our logistic 
regression models were adjusted for the most important confounding variables related to 
cognitive decline, such as: sociodemographic characteristics, health behaviours and chronic 
diseases.  
However, our study also has some limitations. First, the InCHIANTI study was performed 
in community dwelling older subjects living in two sites of the Tuscany region (Italy); 
therefore the sample might not be representative of the general Italian population. Second, 
cognitive decline is a heterogeneous condition and in our study its underlying cause was not 
assessed. Third, our results may be influenced by measurement errors in the dietary 
questionnaires. Furthermore, the present study population is ≥65 years old, and therefore, 
they may be less reliable in recalling food intake than younger subjects. However, the food 
frequency dietary questionnaire was country-specific and previously validated for some 
polyphenol-rich foods, such as fruits, vegetables, tea, coffee and wine, in a similar 
population,
22
 and, moreover, those participants with dementia syndrome at baseline were 
excluded. In addition, dietary consumption of polyphenols may be underestimated, since 
the food composition tables for polyphenols were not totally completed. However, for our 
study an extensive common database was used.
11,18
 
In conclusion, we found that in non-demented older adults higher TUP concentrations were 
associated with a lower risk of substantial cognitive decline over a three-year period after 
adjusting for potential confounders. No significant association was found using TDP. Our 
findings suggest a protective effect of total polyphenols and, indirectly, diets rich in 
polyphenols, against cognitive decline risk in older adults. Further epidemiological studies 
and clinical trials are warranted to clarify the potential preventive role of polyphenols and 
their underlying mechanisms. The identification of factors that reduce or delay cognitive 
decline is essential to improve the autonomy and quality of life of older people.  
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GRAPHICS 
Table 1. Characteristics of the study population according to tertiles of total urinary polyphenols (TUP) and total dietary polyphenols (TDP) 
Characteristic 
All  
(N=652) 
TDP   TUP  
Tertile 1 
(n=217) 
Tertile 2 
(n=218) 
Tertile 3 
(n=217) 
P-
value
a
   
Tertile 1 
(n=217) 
Tertile 2 
(n=218) 
Tertile 3 
(n=217) 
P-
value
a
 
Age, mean (SD) 
73.4  
(6.4) 
75.0  
(7.2) 
73.1  
(6.0) 
72.2  
(5.6) 
<0.00
1 
 
74.8  
(6.9) 
73.8  
(6.5) 
71.8  
(5.3) <0.001 
Female, n (%) 
361  
(55.4) 
148  
(68.2) 
120  
(55.0) 
93  
(42.9) 
<0.00
1 
 
137  
(63.1) 
119  
(54.6) 
105  
(48.4) 0.03 
BMI, kg/m
2
, mean (SD) 
27.6  
(4.0) 
27.6  
(4.2) 
27.5  
(3.9) 
27.6  
(3.7) 0.85 
 
27.2  
(4.0) 
27.6  
(4.0) 
28.0  
(3.8) 0.35 
Education, years, mean 
(SD) 
5.6  
(3.2) 
5.0  
(3.0) 
5.7  
(3.4) 
6.0  
(3.2) 0.07 
 
5.2  
(3.0) 
5.7  
(3.8) 
5.8  
(2.9) 0.54 
Physical activity, n (%)  
    
0.003 
    
0.53 
         Sedentary 
106  
(16.3) 
49  
(22.7) 
36  
(16.5) 
21  
(9.8) 
  
45  
(20.8) 
32  
(14.8) 
29  
(13.4) 
 
         Light 
291  
(44.8) 
106  
(49.1) 
92  
(42.2) 
93  
(43.3) 
  
96  
(44.4) 
101  
(46.8) 
94  
(43.3) 
 
         Moderate to high 
252  
(38.8) 
61  
(28.2) 
90  
(41.3) 
101  
(47.0) 
  
75  
(34.7) 
83  
(38.4) 
94  
(43.3) 
 Smoking status, n (%) 
    
0.04 
    
0.33 
         Never smoker 
387  
(59.4) 
147  
(67.7) 
130  
(59.6) 
110  
(50.7) 
  
138  
(63.6)  
137  
(62.8) 
112  
(51.6) 
 
         Former smoker 
175  
(26.8) 
46  
(21.2) 
53  
(24.3) 
76  
(35.0) 
  
45  
(20.7) 
53  
(24.3) 
77  
(35.5) 
 
         Current smoker 
90  
(13.8) 
24  
(11.1) 
35  
(16.1) 
31  
(14.3) 
  
34  
(15.7) 
28  
(12.8) 
28  
(12.9) 
 Energy intake, kcal/d, 
mean (SD) 
1921 
(549) 
1608  
(437) 
1918  
(456) 
2237  
(558) 
<0.00
1 
 
1830  
(534) 
1909  
(532) 
2024  
(566) 
0.02 
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Dietary fruit and 
vegetables, g/d, median 
(IQR) 
436  
(323-552) 
309 
(245-390) 
445  
(375-525) 
576  
(470-696) 
<0.00
1 
 
416  
(296-538) 
422  
(319-535) 
453  
(365-583) 0.15 
Total dietary polyphenols, 
mg/d, median (IQR) 
574  
(472-701) 
430  
(354-470) 
574  
(543-610) 
766  
(701-855) 
<0.00
1 
 
551  
(452-655) 
562  
(457-708) 
601  
(518-720) 0.12 
Total urinary polyphenols, 
mg GAE/d, median (IQR) 
148  
(113-196) 
138  
(107-173) 
154  
(115-197) 
160  
(126-208) 0.002 
 
103  
(82-113) 
148  
(138-163) 
218  
(196-254) <0.001 
Total cholesterol, mg/dL, 
median (IQR) 
218 
(195-247) 
221 
(195-247) 
220  
(197-251) 
213  
(192-243) 0.09 
 
220  
(195-245) 
216  
(196-248) 
219  
(194-246) 0.62 
Congestive heart failure, n 
(%) 
21  
(3.2) 
6  
(2.8) 
10  
(4.6) 
5  
(2.3) 0.37 
 
5  
(2.3) 
8  
(3.7) 
8  
(3.7) 0.63 
Stroke, n (%) 
32  
(4.9) 
11 
(5.1) 
14  
(6.4) 
7  
(3.2) 0.31 
 
11  
(5.1)  
7  
(3.2) 
14  
(6.5) 0.29 
Cancer, n (%) 
39  
(6.0) 
13  
(6.0) 
13  
(6.0) 
13  
(6.0) 1.00 
 
17  
(7.8) 
6  
(2.8) 
16  
(7.4) 0.06 
Diabetes, n (%) 
88 
(13.5) 
30 
(13.8) 
31 
(14.2) 
27 
(12.4) 0.85  
24  
(11.1) 
27 
(12.4) 
37 
(17.1) 0.15 
Renal impairment, n (%) 
385  
(60.0) 
140  
(66.4) 
128  
(59.3) 
117  
(54.4) 0.76 
 
145  
(67.4) 
128  
(60.4) 
112  
(52.1) 0.44 
Depressive symptoms, 
CES-D score ≥ 16, n (%) 
97  
(14.9) 
35  
(16.1) 
31  
(14.2) 
31  
(14.3) 0.97   
42  
(19.4) 
35  
(16.1) 
20  
(9.2) 0.06 
Cognition tests score, 
mean (SD)           
      MMSE 
25.5  
(3.0) 
25.0  
(3.3) 
25.6  
(2.9) 
25.9  
(2.5) 0.28  
25.0 
(3.4) 
25.6 
(2.9) 
25.9  
(2.5) 0.22 
      TMT-A 
91.3  
(57.2) 
100.9 
(63.5) 
89.4  
(5.51) 
83.7 
(51.4) 0.11  
94.1  
(57.8) 
97.4  
(61.9) 
82.5  
(50.7) 0.20 
      TMT-B 
172.5 
(75.1) 
179.4 
(76.0) 
171.1 
(72.2) 
167.4 
(77.2) 0.54  
176.1 
(76.5) 
174.8  
(76.0) 
166.3 
(72.7) 0.73 
Change in cognition tests           
15 
 
scores, mean (SD) 
      MMSE 
-0.6 
(3.7) 
-0.9  
(4.2) 
-0.5 
(3.2) 
-0.3  
(3.5) 0.74  
-0.9 
(3.7) 
-0.9 
(4.3) 
0.0 
(2.8) 0.09 
      TMT-A 
-8.5 
(41.1) 
-14.8 
(45.1) 
-5.0 
(41.8) 
-6.4 
(35.9) 0.07  
-3.7 
(38.3) 
-13.5 
(48.5) 
-8.3 
(35.4) 0.12 
      TMT-B 
-8.6 
(58.3) 
-14.4 
(58.7) 
0.4 
(57.4) 
-11.7 
(58.6) 0.26  
-8.0 
(58.2) 
-2.6 
(50.3) 
-14.5 
(64.8) 0.48 
Substantial cognitive 
decline, n (%)
b
           
      MMSE 
203  
(31.1) 
68  
(31.3) 
73  
(33.5) 
62  
(28.6) 0.57  
80  
(36.9) 
71  
(32.6) 
52  
(24.0) 0.07 
      TMT-A 
103 
(20.2) 
42  
(24.7) 
36  
(21.2) 
25  
(14.7) 0.24  
46  
(27.1) 
33  
(19.4) 
24  
(14.1) 0.04 
      TMT-B 
221  
(52.2) 
73  
(51.8) 
78  
(55.3) 
70  
(49.6) 0.57  
74  
(52.5) 
76  
(53.9) 
71  
(50.4) 0.95 
a
Generalized linear models were adjusted for age. 
b
Substantial cognitive decline was defined as ≥ 3 points on the MMSE from baseline to three years later and as the worst 10% of the distribution 
of subtracting baseline from three year follow-up scores in seconds or  test discontinued at follow-up for the Trails A and B. 
SD = standard deviation; IQR = interquartile range; BMI = body mass index; CES-D = center for epidemiologic studies depression scale; MMSE 
= mini-mental state examination; TMT = trail making tests. 
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Table 2. Logistic regression models describing the association between total urinary polyphenols (TUP) tertiles and three-year substantial 
cognitive decline in older subjects 
 
MMSE
a
 
 
TMT-A
a
 
 
TMT-B
a
 
  Cut-off 
No. of 
cases 
OR  
(95% CI) 
  Cut-off 
No. of 
cases 
OR  
(95% CI) 
  Cut-off 
No. of 
cases 
OR  
(95% CI) 
 
mg GAE/d n 
  
mg GAE/d n 
  
mg GAE/d n 
 Model A
b
 
          
Tertile 1 <126.4 80 
1 
(reference) 
 
<133.2 46 
1 
(reference) 
 
<135.8 74 
1 
(reference) 
Tertile 2 
126.4-
175.5 
71 
0.82  
(0.55-1.21) 
 
133.2-
183.7 
33 
0.56  
(0.32-0.97) 
 
135.8-
186.8 
76 
0.99  
(0.60-1.64) 
Tertile 3 >175.5 52 
0.53  
(0.35-0.80) 
 
>183.7 24 
0.50  
(0.28-0.89) 
 
>186.8 71 
0.90  
(0.54-1.49) 
P-trend
c
 
  
0.003 
   
0.02 
   
0.67 
Continuous 
(log2) 
 
203 
0.69  
(0.52-0.92) 
  
103 
0.60  
(0.41-0.90) 
  
221 
1.03  
(0.71-1.50) 
            Model B
d
 
          
Tertile 1 <126.4 80 
1 
(reference) 
 
<133.2 46 
1 
(reference) 
 
<135.8 74 
1 
(reference)] 
Tertile 2 
126.4-
175.5 
71 
0.79  
(0.51-1.22) 
 
133.2-
183.7 
33 
0.55  
(0.31-0.99) 
 
135.8-
186.8 
76 
1.08  
(0.63-1.84) 
Tertile 3 >175.5 52 
0.53  
(0.34-0.85) 
 
>183.7 24 
0.52  
(0.28-0.96) 
 
>186.8 71 
0.95  
(0.56-1.62) 
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P-trend
c
 
  
0.008 
   
0.03 
   
0.84 
Continuous 
(log2) 
 
203 
0.71  
(0.51-0.97) 
  
103 
0.65  
(0.42-0.99) 
  
221 
1.11  
(0.73-1.67) 
a
Substantial cognitive decline was defined as ≥ 3 points on the MMSE and as the worst 10% of the distribution of subtracting baseline from three 
year follow-up scores in seconds or  test discontinued at follow-up for the Trails A and B. 
b
Adjusted for baseline cognitive score only. 
c
P-trend obtained by assigning the median of each tertile as scores. 
d
Adjusted for baseline cognitive score, sex, age, education, body mass index, total energy intake, physical activity, total cholesterol, impaired 
renal function, smoking status, congestive heart failure, cancer, stroke, diabetes and depressive symptoms. 
TUP = total urinary polyphenols; GAE = gallic acid equivalents; OR = odds ratio; CI = confidence interval; MMSE = mini-mental state 
examination; TMT = trail making tests. 
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Figure 1. Flow chart of participants at each stage of the study.  
MMSE = mini-mental state examination; TMT = trail making tests. 
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Supplementary Appendix 1 
Table S1. Logistic regression models describing the association between total dietary polyphenols (TDP) tertiles and three-year substantial 
cognitive decline in older subjects 
 
MMSE
a
 
 
TMT-A
a
 
 
TMT-B
a
 
  Cut-off 
No. of 
cases 
OR  
(95% CI) 
  Cut-off 
No. of 
cases 
OR  
(95% CI) 
  Cut-off 
No. of 
cases 
OR  
(95% CI) 
 
mg/d n 
  
mg/d n 
  
mg/d n 
 Model A
b
 
          
Tertile 1 <514.2 68 
1 
(reference) 
 
<520.6 42 
1 
(reference) 
 
<525.7 73 
1 
(reference) 
Tertile 2 
514.2-
648.4 
73 
1.09  
(0.73-1.64) 
 
520.6-
659.3 
36 
1.04  
(0.60-1.79) 
 
525.7-
676.3 
78 
1.61  
(0.96-2.69) 
Tertile 3 >648.4 62 
0.86  
(0.57-1.31) 
 
>659.3 25 
0.66  
(0.37-1.20) 
 
>676.3 70 
1.18  
(0.70-1.98) 
P-trend
c
 
  
0.45 
   
0.16 
   
0.70 
Continuous 
(log2) 
 
203 
0.83  
(0.59-1.18) 
  
103 
0.86  
(0.53-1.38) 
  
221 
1.23  
(0.80-1.89) 
            Model B
d
 
          
Tertile 1 <514.2 68 
1 
(reference) 
 
<520.6 42 
1 
(reference) 
 
<525.7 73 
1 
(reference) 
Tertile 2 
514.2-
648.4 
73 
1.26  
(0.80-1.97) 
 
520.6-
659.3 
36 
1.09  
(0.61-1.96) 
 
525.7-
676.3 
78 
1.62  
(0.94-2.80) 
Tertile 3 >648.4 62 
1.08  
(0.65-1.78) 
 
>659.3 25 
0.63  
(0.32-1.25) 
 
>676.3 70 
1.16  
(0.63-2.14) 
P-trend
c
 
  
0.84 
   
0.17 
   
0.77 
Continuous 
(log2) 
 
203 
0.91  
(0.59-1.42) 
  
103 
0.79  
(0.44-1.40) 
  
221 
1.24  
(0.74-2.09) 
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aSubstantial cognitive decline was defined as ≥ 3 points on the MMSE and as the worst 10% of the distribution of subtracting baseline from three 
year follow-up scores in seconds or  test discontinued at follow-up for the Trails A and B. 
b
Adjusted for baseline cognitive score only. 
c
P-trend obtained by assigning the median of each tertile as scores. 
d
Adjusted for baseline cognitive score, sex, age, education, body mass index, total energy intake, physical activity, total cholesterol, impaired 
renal function, smoking status, congestive heart failure, cancer, stroke, diabetes and depressive symptoms. 
TDP = total dietary polyphenols; OR = odds ratio; CI = confidence interval; MMSE = mini-mental state examination; TMT = trail making tests. 
 
